logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: pathology
Load new posts () and activity
Like Reblog Comment
text 2022-02-15 12:26
Anatomic pathology market is projected to reach $ 49.1 billion by 2026, at a CAGR of 7.0%

The major factors that are expected to be driving the high content screening market are need for cost containment in pharma R&D, growth in funding for cellular research, and technological advancements in HCS solutions are expected to support the growth of the HCS market during the forecast period

What the Market Looks Like?

[343 Pages Report] The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). 

COVID -19 Impact on Anatomic Pathology Market

Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.

What are Key Trends in the Market?

The growth of the Anatomic Pathology Market is primarily influenced by the following factors:

  • High incidence of cancer and other target diseases
  • Recommendations for cancer screening
  • Availability of reimbursement
  • Growing focus on personalized medicine
  •  Increasing number of clinical trials pertaining to cancer drugs
  • Emerging markets offer lucrative opportunities

Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market in 2020 due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

Read more about Anatomic Pathology Market
https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

Like Reblog Comment
text 2021-09-28 12:27
Anatomic Pathology Market Worth USD 46.8 Billion By 2025 : High incidence of cancer and other target diseases

The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.

[306 Pages Report] The global anatomic pathology market size is estimated to grow from USD 33.3 billion in 2020 to USD 46.8 billion by 2025, at a CAGR of 7.1%.

Market Dynamics

  • High incidence of cancer and other target diseases
  • Recommendations for cancer screening
  • Availability of reimbursement
  • Growing focus on personalized medicine

COVID-19 Impact on Anatomic Pathology Market

Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.

Download PDF Brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145 

By product & service, the anatomic pathology market is segmented into services, instruments, and consumables. The services segment accounted for the largest market share in 2019 and is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the availability of reimbursements for diagnostic tests, rapid growth in the geriatric population, and the increasing incidence of cancer and other chronic diseases.

The geographical regions mapped in the report are:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • Latin America
  • Middle East & Africa

Based on the region, the global anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest market share, followed by Europe. The easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the anatomic pathology market in North America.

Request for sample pages @   https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html 

Some key players mentioned in the research report are:

Prominent players in the anatomic pathology market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Hologic, Inc. (US), Agilent Technologies (US), Becton, Dickinson and Company (US), PHP Holdings Corporation (Japan), Sakura Finetek (Japan), Merck KGaA (Germany), Bio SB (US), Diapath S.p.A. (OTCPK:ITALY), and BioGenex Laboratories (US).

Source: www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html
Like Reblog Comment
text 2021-08-23 08:32
Digital Pathology Market to Expand Steadily in the Coming Years till 2014-2025

The global Digital Pathology Market is predicted to witness substantial growth in the coming years due to increasing need to improve the existing diagnostics imaging measures and reduce the cost of traditional diagnostics. Digital pathology is a powerful image-based environment for data acquisition and interpretation of examined data obtained from the slide. It is majorly used in healthcare applications and life sciences.

 

Access Sample Report of this report @ https://bit.ly/3z56l2x

 

 

Currently, digital pathology is indispensable to gain a wide popularity since it greatly assists the healthcare professionals in diagnosis and treatment, specifically supports the education domain, used widely in research and development of large number of drugs, and also it is an important tool for human laboratory practice on the global scale. It delivers improved analysis that helps physicians and experts in decision making, speedy access to emergency cases, and data storage for future predictive analysis, offers live zooming option with multiple angle views, enable team annotation for slides, and reduce errors or misidentification.

 

The key drivers of the digital pathology market include increasing awareness of digital pathology across the globe and growing adoption, rising technological enhancement in the analysis software, increasing prevalence of cancer, high efficiency of pathological assessment, increased workload of pathologists, and delivery of superior results. However, strict regulations and significant cost of the systems are few restraining factors in the digital pathology industry.

 

Increasing focus on improving the efficiency of workflow and adoption of quicker diagnostic tools for chronic disorders is trending in the digital pathology market. Nonetheless, digital pathology has several advantages over the traditional techniques, which is expected to offer lucrative opportunity for various applications.

 

With an aim of improving digital pathology services, Neuberg Diagnostics, a prominent player in the industry merged with OptraSCAN Inc. US, for the introduction of ‘Neuberg DIGIPATH by OptraSCAN Inc’. With a highly proficient team based in UAE, India, and South Africa, this venture offers solution for digitized tissue slides and tele-pathology demanded by medical institutes, hospitals, and the physicians.

 

Moreover, since the digital pathology domain is gaining momentum in India, the associated instruments are significantly priced, making it difficult for the customers to purchase. But the services offered by this merger are predicted to support pathologists and private hospitals in terms of better-quality scanner, telepathology software platform, image management tools, along with Neuberg’s histopathology network.

 

The leading players are OLYMPUS CORPORATION, Sectra AB, F. Hoffmann-La Roche Ltd, Mikroscan Technologies, Inc., Leica Biosystems Imaging Inc., GE Healthcare, Inspirata, and Koninklijke Philips N.V.

 

Browse Full Report With TOC @ https://bit.ly/3y8SQO5

 

Market Segment:

Digital Pathology Technology Outlook (Revenue, USD Million; Volume, 000 Units, 2014 - 2025)
    • Whole Slide Imaging
    • Telepathology
        • Static
        • Dynamic

 

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

Like Reblog Comment
text 2021-07-13 16:16
PHYSIOLOGY AND PATHOLOGY OF SICKLE CELL ANEMIA

The human body is created astonishingly. Every part and system is precise and perfect in performing its desired functions. Blood is one of the core bases of life. If the blood functioning is disrupted due to any reason, then the consequences can be very severe, chronic, and sometimes fatal. The associated blood diseases sometimes tend to follow a genetic or inherited pattern. The blood abnormality we are about to discuss today is strictly genetic and can be fatal at times.

 

WHAT IS SICKLE CELL ANEMIA:

 

Sickle Cell Anemia or Sickle Cell Disease (SCD) is a blood disease following a genetic trial. In this disease, the regular disc shape of the Erythrocytes becomes abnormal sickle or crescent-shaped. The erythrocytes, due to irregular shape transformation, find it difficult to pass the blood vessels. It also affects the oxygen-carrying capacity of the Red Blood Corpuscles.

The sickle-shaped Erythrocytes become rigid and prone to getting stuck in the blood vessels causing cytological and histological damages within the body.

 

SYMPTOMS OF SICKLE CELL ANEMIA:

 

Every medical abnormality is followed by sure signs and symptoms that help in diagnosing the disease. Following the same, the prime symptoms that help in identifying sickle cell anemia are given below:

 

  • Hemolysis: 

Rapid destruction of erythrocytes. 

 

  • Optic Dysfunction:

The patient is observed to suffer from an incurable vision problem as the tiny optic vessels get plugged, causing damages to the retina and the vision automatically.

 

  • Adema:

Swelling and over swelling of hands and feet mainly. In cases, swelling is observed on the whole body.

 

  • Jaundice:

The eyes and skin turn yellow, followed by weakness.

 

  • Frequent Infections

The patient suffers from infection frequently, which ends up weakening the immune system of the patient. Damage of the spleen causes fatal and chronic conditions in the patient.

 

  • Anemia:

Due to the rapid destruction of the erythrocytes, the patient suffers from anemic critical conditions. It is one of the significant symptoms of sickle cell anemia.

 

CAUSES OF SICKLE CELL ANEMIA:

 

  • Genetic Cause:

Sickle cell anemia is caused by the mutation in the gene that is responsible for carrying the relevant genetic information about the production of hemoglobin (the iron-rich compound that gives the blood its red color, enabling the erythrocytes to carry the oxygen from the lungs throughout the human body.

 

  • Congenital Cause:

The transferring of the mutated gene is also in the body of the fetus,

 

MEDICAL COMPLICATIONS OF SICKLE CELL ANEMIA: 

 

Acute Chest Syndrome:

The life-threatening condition in which the sickle cell erythrocytes block the blood vessels of the lungs causing difficulty in breathing. Sometimes it may lead to Pneumonitis (inflammation in the lungs).

 

Leg Ulcer:

Swelling is observed on the entire body, including the legs and hands particularly. This condition is termed a leg ulcer.

 

Organ damage:

Lack of oxygen-rich blood in the organs causes dysfunction of the organs, including kidney, liver, spleen, etc. In many observed cases, the deficiency of oxygen-rich blood had been fatal to the patients. 

 

Eye abnormalities:

Blockage in the eye vessels of the body can cause severe damages to the visions and visuals of the patient.

 

Neurological Complications:

Oxygen-Rich blood is most important for the proper functioning of our brain. The deficiency of oxygen can cause severe damages to the brain resulting in epilepsy, seizures, and strokes. 

 

Sometimes the patient is observed to slip into a comma. All of these abnormalities are caused by the blockage of the brain.

 

Delayed Growth:

The retardation of physical growth is observed in the children specifically. It is a possibility that the children face delayed development in their childhood, but they might retain their growth usually in their adulthood.

 

Sex maturation is also an evidential complication observed as a consequence of sickle cell anemia.

 

LABORATORY DIAGNOSIS:

Blood Tests:

As sickle cell anemia is a blood-associated disease, so blood diagnosis is the best cheap and reliable test to diagnose the condition.

 

  • CBC or Complete Blood Count:

 

Helps in estimating the count of erythrocytes in the blood. Decreased amount of RBCs proves that the patient is facing some severe hemolytic effects.

 

  • Blood Smears:

 

The formation of blood smears aids in estimating the average and contracted number of cells circulating in the blood.

 

  • Sickle solubility test:

 

This test helps graph the concentration of hemoglobin (Hb) in the blood. Decreased concentration will increase the possibility of the disease.

 

TREATMENT:

 

Bone Marrow Transplant:

 

Sickle cell anemia is difficult to treat with drugs and medications. The most effective way to cure this disorder of blood is a bone marrow transplant. As the disease causes hemolysis (destruction of RBCs), bone marrow transplant will aid in the formation of new blood cells decreasing the destructions of the cells.

 

Medications to increase fetal hemoglobin:

 

Droxia and Hydrea help in increasing the fetal hemoglobin in the body.

Sickle cell anemia can be fatal and can cause death if not treated on time. You can get many resources like Researchomatic, Wikipedia, etc from where you can get more details about the said topic.

Source: www.researchomatic.com/sickle-cell-anemia-icon-of-evolution-158753.html
More posts
Your Dashboard view:
Need help?